Intervention Review

Corticosteroids for myasthenia gravis

  1. Christiane Schneider-Gold1,
  2. Philippe Gajdos2,*,
  3. Klaus V Toyka3,
  4. Reinhard R Hohlfeld4

Editorial Group: Cochrane Neuromuscular Group

Published Online: 20 APR 2005

Assessed as up-to-date: 27 JUN 2010

DOI: 10.1002/14651858.CD002828.pub2

How to Cite

Schneider-Gold C, Gajdos P, Toyka KV, Hohlfeld RR. Corticosteroids for myasthenia gravis. Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD002828. DOI: 10.1002/14651858.CD002828.pub2.

Author Information

  1. 1

    University of Göttingen, Department of Neurology, Göttingen, Germany

  2. 2

    Hopital Raymond Poincaré (APHP), Service de Réanimation, 92380 Garches, Ile de France, France

  3. 3

    University of Würzburg, Neurology, Würzburg, Bavaria, Germany

  4. 4

    University of Munich, Institute for Clinical Neuroimmunology, Munich, Germany

*Philippe Gajdos, Service de Réanimation, Hopital Raymond Poincaré (APHP), 104, Boulevard Raymond Poincaré, 92380 Garches, Ile de France, France.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 20 APR 2005


  1. Current Version

    Corticosteroids for myasthenia gravis

    Christiane Schneider-Gold, Philippe Gajdos, Klaus V Toyka and Reinhard R Hohlfeld

    Version of Record online: 20 APR 2005 | DOI: 10.1002/14651858.CD002828.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Corticosteroids for myasthenia gravis

    C Schneider, R Hohlfeld and K Toyka

    Version of Record online: 23 OCT 2000 | DOI: 10.1002/14651858.CD002828